Newsfeeds - Spark Newswire

6 minute read

This Legal Psychoactive Mushroom Reduces Stress And Pain And Encourages Longevity, Expert Says

Today, 6:06 AM

This article was originally published in December 2021. Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood.

HAVLF

1 minute read

Learn About HAVN Life’s New Shares Consolidation, What Changes And What Remains

By Lara Goldstein

Today, 6:06 AM

A key player in the biotech-meets-psychedelics space, HAVN Life Sciences Inc.

HAVLF

2 minute read

Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin

By Lara Goldstein

Today, 6:06 AM

TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace.

FLHLF

2 minute read

HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details

By Lara Goldstein

Today, 6:06 AM

Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC: HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its therapeutic retreats in Jamaica and Optimi Health Corp.

HAVLF

2 minute read

HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market

By Nicolas Jose Rodriguez

Today, 6:06 AM

HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for investigational research to support brain health and cognitive function, announced on Thursday its entry into an exclusive U.S.

CSE:HAVN